Evidence map›Paper›PMID 20626664›Full record

Trial reportPreventive cardiology2010

A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design.

Paul D Thompson, Beth A Parker, Priscilla M Clarkson, Linda S Pescatello, C Michael White, Adam S Grimaldi, Benjamin D Levine, Ronald G Haller, Eric P Hoffman

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Preventive cardiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Effect of statins on skeletal muscle function.Circulation · 2013 · on this map
    Trial
  7. Trial
  8. Trial
  9. Relation of vitamin D level to maximal oxygen uptake in adults.The American journal of cardiology · 2011
    Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Paul D ThompsonDivision of Cardiology, Henry Low Heart Center, Hartford Hospital, Hartford, CT 06102, USA. pthomps@harthosp.org
Beth A Parker
Priscilla M Clarkson
Linda S Pescatello
C Michael White
Adam S Grimaldi
Benjamin D Levine
Ronald G Haller
Eric P Hoffman
Hartford Hospital · USDallas VA Medical Center · USUniversity of Connecticut · USNewYork–Presbyterian Hospital · USUniversity of Massachusetts Amherst · US

Funding

Wellstone Muscular Dystrophy Center: Children's Nat'l Med CtrU54HD053177 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI HOFFMAN, ERIC P. · 2005 to 2009
$7.3M
Functional SNP's Assoc with Human Muscle Size &StrengthR01NS040606 · NINDS · CHILDREN'S RESEARCH INSTITUTE · PI HOFFMAN, ERIC P · 2001 to 2004
$4.7M
Functional SNPs Associated with Human Muscle Size and StrengthR01AR055100 · NIAMS · CHILDREN'S RESEARCH INSTITUTE · PI HOFFMAN, ERIC P. · 2007 to 2010
$3.0M
The Effect of Statins on Skeletal Muscle FunctionR01HL081893 · NHLBI · HARTFORD HOSPITAL · PI THOMPSON, PAUL DAVIS · 2007 to 2010
$2.9M
NHLBI NIH HHS R01 HL081893NHLBI NIH HHS R01 HL081893A2NIAMS NIH HHS R01 AR055100NICHD NIH HHS U54 HD053177NINDS NIH HHS R01 NS040606
6 · The paper itself

Abstract

Hydroxymethylglutaryl-coenzyme A reductase inhibitors or statins are the most effective medications for reducing elevated concentrations of low-density lipoprotein cholesterol (LDL-C). Statins reduce cardiac events in patients with coronary artery disease and previously healthy persons. Current recommendations for LDL-C treatment goals indicate that more patients will be treated with higher doses of these medications. Statins have been extremely well-tolerated in controlled clinical trials but are increasingly recognized to produce skeletal muscle myalgia, cramps, and weakness. The reported frequency of such mild symptoms is not clear, and muscle performance has not been examined with these medications. Accordingly, the present investigation, the Effect of Statins on Skeletal Muscle Function and Performance (STOMP) study, will recruit approximately 440 healthy persons. Participants will be randomly assigned to treatment with atorvastatin 80 mg/d or placebo. Handgrip, elbow and knee isometric and isokinetic strength, knee extensor endurance, and maximal aerobic exercise performance will be determined at baseline. Participants will undergo repeat testing after 6 months of treatment or after meeting the study definition of statin myalgia. This study will determine the effect of statins on skeletal muscle strength, endurance, and aerobic exercise performance and may ultimately help clinicians better evaluate statin-related muscle and exercise complaints.

Indexed as

AtorvastatinCholesterol, LDLCoronary Artery DiseaseCreatine KinaseDecision TreesDouble-Blind MethodExercise TestFemaleHealth Status IndicatorsHeptanoic AcidsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypercholesterolemiaIsometric ContractionMaleMotor ActivityAtorvastatinCholesterol, LDLCreatine KinaseHeptanoic AcidsHydroxymethylglutaryl-CoA Reductase InhibitorsPyrroles

Identifiers

PMID20626664
PMCPMC4107659
OpenAlexW2051275083

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.